Is STANDARD BIOTOOLS INC. (LAB) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 8.7% / 30% | 76.9% / 30% | 8.8% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 8.7% / 33% | 76.9% / 33% | 8.8% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 5.4% / 33% | 47.8% / 33% | 5.5% / 33% | N/A | ✗ NOT HALAL |
| S&P | 8.7% / 33% | 76.9% / 33% | 8.8% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 5.4% / 33% | 47.8% / 33% | 5.5% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 49.9% | |
| Operating Margin | -29.4% | |
| Net Margin | -87.8% | |
| Return on Equity (ROE) | -13.1% | |
| Return on Assets (ROA) | -9.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$74M |
| Free Cash Flow | -$83M |
| Total Debt | $31M |
| Debt-to-Equity | 118.0 |
| Current Ratio | 4.2 |
| Total Assets | $568M |
Price & Trading
| Last Close | $0.96 |
| 50-Day MA | $1.18 |
| 200-Day MA | $1.28 |
| Avg Volume | 1.9M |
| Beta | 1.4 |
|
52-Week Range
$0.90
| |
About STANDARD BIOTOOLS INC. (LAB)
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is STANDARD BIOTOOLS INC. (LAB) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), STANDARD BIOTOOLS INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is STANDARD BIOTOOLS INC.'s debt ratio?
STANDARD BIOTOOLS INC.'s debt ratio is 8.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.4%.
What are STANDARD BIOTOOLS INC.'s key financial metrics?
STANDARD BIOTOOLS INC. has a market capitalization of $350M, and revenue of $85M. The company maintains a gross margin of 49.9% and a net margin of -87.8%. Return on equity stands at -13.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.